Hypnosis and VR tested to calm leukemia Patients' fears

NCT ID NCT07386392

Not yet recruiting Symptom relief Sponsor: University Hospital, Toulouse Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares hypnosis, virtual reality, and standard care to see which best reduces anxiety in adults starting chemotherapy for acute myeloid leukemia. About 99 patients will be randomly assigned to one of three groups. The goal is to find a non-drug way to help patients cope with the stress of diagnosis and intensive treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: hypnosis and virtual reality sessions
What this could lead to: If it works, this could offer simple, drug-free ways to ease severe anxiety during leukemia treatment, improving patient well-being.
What could go wrong: This is a small pilot study (99 people) that hasn't started yet. The effects may be small or not last, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute myeloid leukemia anxiety disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE MYELOID LEUKEMIA

Contacts and locations

Locations

IUCT Oncopole

Toulouse, France, 31059, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.